Get started
Author

Michaela Karagianni

Observed name: M. Karagianni
Institution: University of Crete
OpenAlex ID: A5020682000
Prognostic Value of KRAS Mutations in Colorectal Cancer Patients
2022 · Asimina Koulouridi, Michaela Karagianni, et al. · Cancers · 68
PDF
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies
2024 · Enric Domingo, Caroline Kelly, et al. · Journal of Clinical Oncology · 34
Investigation of Microbial Translocation, TLR and VDR Gene Polymorphisms, and Recurrence Risk in Stage III Colorectal Cancer Patients
2022 · Ippokratis Messaritakis, Asimina Koulouridi, et al. · Cancers · 12
PDF
Exploring Gut Microbiome Composition and Circulating Microbial DNA Fragments in Patients with Stage II/III Colorectal Cancer: A Comprehensive Analysis
2024 · Ippokratis Messaritakis, Andreas Koulouris, et al. · Cancers · 7
Real-world efficacy and toxicity data of paclitaxel and ramucirumab compared with other treatment regimens in patients with advanced gastric cancer
2024 · E. Fountzilas, J. Souglakos, et al. · ESMO Gastrointestinal Oncology · 5
PDF
Metabolic acidosis in dyslipidemia with acute renal failure in pioglitazone/metformin treatment a case report
2024 · Georgios Chatzis, Maria Vlachopoulou, et al. · Atherosclerosis · 1
PDF
Circulating Tumor Cells and Cell-Free DNA during Three or Six Months of Adjuvant Chemotherapy in Stage III Colorectal Cancer
2026 · Asimina Koulouridi, Ippokratis Messaritakis, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
PDF
96P Integrative risk stratification in stage II-III colorectal cancer: Associations between molecular alterations, microbial translocation, and TLR polymorphisms
2025 · A.V. Koulouris, I. Messaritakis, et al. · Annals of Oncology
PDF
94P Integrating circulating biomarkers, TLRs/VDRs polymorphisms and microbial translocation for prognosis in stage III colorectal cancer
2025 · A. Koulouridi, I. Messaritakis, et al. · Annals of Oncology
9P Circulating tumor cells and circulating tumor DNA detection in colorectal cancer stage III patients receiving three or six months of adjuvant treatment
2024 · A. Koulouridi, I. Messaritakis, et al. · ESMO Open
PDF
139P Young onset colorectal cancer: Clinical and molecular characteristics
2024 · C. Cortas, G.M. Saridakis, et al. · Annals of Oncology
P-158 Comprehensive recurrence risk assessment after colectomy, for stage II and III colorectal cancer patients, using genetic profiling, microbiome, and circulating tumor markers
2022 · I. Messaritakis, M. Sfakianaki, et al. · Annals of Oncology
Works count: 12
Citation count: 127
H-index: 5
I10-index: 3
Year
Topic
Type